[Clinical features of spastic dysphonia]

Area of Science:

• Neurology
• Speech-Language Pathology

Background:

• Spastic dysphonia is a complex voice disorder.
• Its underlying pathophysiology requires further elucidation.

Purpose of the Study:

• To investigate the neurological basis of spastic dysphonia.
• To evaluate the efficacy of a combined treatment approach.

Main Methods:

• Clinical, neurological, and endoscopic examinations.
• Questionnaire data, voice assessments, and diagnostic imaging.
• Treatment involved GABA-ergic drugs (clonazepam, baclofen), voice therapy, and physiotherapy.

Main Results:

• Evidence supports an organic neurological etiology for spastic dysphonia, classifying it as focal muscular dystonia.
• Associated conditions include tremors and other dystonias.
• The combined treatment regimen yielded positive therapeutic results.

Conclusions:

• Spastic dysphonia is a neurological focal muscular dystonia.
• Combined treatment is pathogenetically justified and effective.